Pfizer UK has appointed a new managing director

announced the appointment of Ben Osborn as UK managing director, replacing Erik Nordkamp, who will become Pfizer's UK general manager of the pharmaceutical business and leader of the European group.Ben has been part of Pfizer for 20 years and has been a marketing organization in Pfizer's innovative pharmaceutical business since 2015., he was head of oncology at Pfizer UK, where he helped develop Cancer UK policy through collaborations with the government, patient groups and co-chairs of the ABPI Cancer Group.commenting on his appointment, Ben said: "I am delighted to be back in business in the UK and to be managing director of the UK at such an important time.a new era of partnership between the health service and the industry is crucial to achieving the best conditions for patients in the UK at a critical time for the NHS in its long-term plans," he said. That's why we're very keen to develop new ones and build existing relationships with the government and the NHS to try to help achieve that.Ben will take over from Erik Nordkamp, who has led the UK company successfully for almost four years., he also served as chairman of the American Pharmaceutical Group (APG) and chairman of the British Pharmaceutical Association (ABPI). Erik continues to work in the UK and will continue to serve as ABPI's president until ABPI's next annual general meeting in April 2019. (This net special article)